We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
-15.33%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$1.87B
AUM Growth
-$449M
(-19%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
358
New
37
Increased
55
Reduced
86
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$48.3M |
| 2 |
UnitedHealth
UNH
|
+$32.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$19.2M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.8M |
| 5 |
CME Group
CME
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$39.5M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$26.5M |
| 3 |
Freeport-McMoran
FCX
|
+$17.7M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$17.1M |
| 5 |
Regal Rexnord
RRX
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.02% |
| 4 | Financials | 12.7% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Antero Resources
AR
$10.9B
| $2.15M | 0.12% |
70,320
-51,020
| -42% | -$1.87M |
|
|
MMP
152
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.11M | 0.11% |
44,088
| – | – |
|
153
Helmerich & Payne
HP
$3.34B
| $2.1M | 0.11% |
48,680
| – | – |
|
154
Supernus Pharmaceuticals
SUPN
$2.7B
| $2.08M | 0.11% |
71,990
+30,010
| +71% | +$860K |
|
155
Aptiv
APTV
$12.3B
| $2.08M | 0.11% |
23,345
-1,730
| -7% | -$177K |
|
156
Range Resources
RRC
$9.33B
| $2.08M | 0.11% |
83,970
-47,180
| -36% | -$1.45M |
|
157
Viper Energy
VNOM
$8.43B
| $2.07M | 0.11% |
77,505
| – | – |
|
158
EOG Resources
EOG
$77.7B
| $2.07M | 0.11% |
18,705
-2,960
| -14% | -$367K |
|
159
Baker Hughes
BKR
$58.3B
| $2.06M | 0.11% |
71,230
| – | – |
|
160
DoubleVerify
DV
$1.77B
| $2.05M | 0.11% |
+90,460
| New | +$2.03M |
|
161
PNC Financial Services
PNC
$99.1B
| $2.05M | 0.11% |
12,985
-12,980
| -50% | -$2.18M |
|
162
Halliburton
HAL
$26.1B
| $2.04M | 0.11% |
65,000
-166,300
| -72% | -$6.2M |
|
|
PXD
163
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.04M | 0.11% |
9,122
-2,070
| -18% | -$525K |
|
164
Targa Resources
TRGP
$56.8B
| $1.97M | 0.11% |
32,960
| – | – |
|
165
Occidental Petroleum
OXY
$55.7B
| $1.97M | 0.11% |
33,385
-11,130
| -25% | -$684K |
|
166
Cheniere Energy
CQP
$30.5B
| $1.94M | 0.1% |
43,274
| – | – |
|
167
Freshpet
FRPT
$3.04B
| $1.87M | 0.1% |
36,028
-5,443
| -13% | -$420K |
|
168
Chevron
CVX
$382B
| $1.81M | 0.1% |
12,520
-4,170
| -25% | -$689K |
|
|
RVNC
169
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.79M | 0.1% |
+129,313
| New | +$1.99M |
|
|
PDCE
170
DELISTED
PDC Energy, Inc.
PDCE
| $1.73M | 0.09% |
28,060
| – | – |
|
171
Agnico Eagle Mines
AEM
$72.2B
| $1.72M | 0.09% |
37,500
| – | – |
|
172
Diamondback Energy
FANG
$56B
| $1.71M | 0.09% |
14,145
-4,710
| -25% | -$645K |
|
173
TSMC
TSM
$1.94T
| $1.64M | 0.09% |
20,080
| – | – |
|
174
Harmonic Inc
HLIT
$1.15B
| $1.58M | 0.08% |
182,768
-65,940
| -27% | -$594K |
|
175
Wynn Resorts
WYNN
$10.3B
| $1.56M | 0.08% |
27,400
| – | – |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2022 Portfolio in Review
As of Q2 2022, Castleark Management held 358 positions worth $1.87B, down 19% from $2.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Castleark Management withdrew a net $58.7M in Q2 2022, closing 52 positions and reducing 86 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in State Street SPDR S&P Biotech ETF worth $47.8M.
- Castleark Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 643,890 shares worth $47.8M.
- Castleark Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.8M increase.
- Castleark Management's biggest Q2 2022 reduction was Microchip Technology, cutting an estimated $39.5M.
- Castleark Management fully exited State Street Materials Select Sector SPDR ETF in Q2 2022, selling an estimated $26.5M.
- Castleark Management's ten largest holdings make up 33% of its $1.87B portfolio in Q2 2022.
- Castleark Management opened 37 new positions and closed 52 in Q2 2022.
- Castleark Management's portfolio value fell 19% quarter-over-quarter to $1.87B.
Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.